Eisai

Anonymous board for Eisai.
Post thread


Exel kicks out butts again
Replies
3
Views
291
anonymous
Purity Patent? Will they address it in Orlando?
Replies
4
Views
340
anonymous
Oncology division
Replies
692
Views
104K
anonymous
I learned something this past weekend...
Replies
26
Views
3K
anonymous
Eisai Lowers Sales Expectations for Leqembi Again, Citing Slow US Uptake - BioSpace
Replies
10
Views
1K
anonymous
Well… that didn’t work
Replies
5
Views
737
anonymous
Eisai lays out road map to blockbuster sales projections for Leqembi's 'milestone' 2027 year | Fierce Pharma
Replies
2
Views
495
anonymous
Alex Scott did the dude no more.
Replies
1
Views
569
anonymous
Biogen, Eisai’s Leqembi Suffers Overseas Setbacks as UK Denies Coverage, Australia Denies Approval - BioSpace
Replies
1
Views
337
anonymous
FiercePharma: In UK, it's strike 2 for Alzheimer's treatments from Lilly and Biogen/Eisai
Replies
0
Views
205
anonymous
Glad I invest in EXEL
Replies
12
Views
1K
anonymous
Australia stands firm on 'no' to Alzheimer's drug Leqembi | pharmaphorum
Replies
0
Views
132
anonymous
Fierce Pharma - Eisai telegraphs 121 layoffs in US amid new restructuring drive
Replies
4
Views
893
anonymous
Did an Alzheimer’s drug give Sue and Ken Bell more time? Maybe : Shots - Health News : NPR
Replies
4
Views
429
anonymous
Who is benefiting from the amyloid hypothesis of Alzheimer’s? | STAT
Replies
7
Views
713
anonymous
Eisai execs flag Leqembi 'expansion phase' on the horizon as Alzheimer's med grows slowly
Replies
0
Views
414
anonymous
As US Sales of Leqembi Lag, Eisai Eyes SubQ Approvals - BioSpace
Replies
3
Views
476
anonymous
Biogen, Eisai Win Nod for Monthly Leqembi Maintenance Amid Stagnant Sales - BioSpace
Replies
3
Views
465
anonymous
Fierce Parma - Merck, Eisai combo misses survival goal in GI cancer trial
Replies
2
Views
347
anonymous
Amyloid Hypothesis in Doubt as Newly Approved Drugs Hit Hurdles - BioSpace
Replies
21
Views
2K
anonymous
Top Bottom
Back
Post thread